Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'fotemustine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 61 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kuroiwa, M; Ikeda, H; Hongo, T; Tsuchida, Y; Hirato, J; Kaneko, Y; Suzuki, N; Obana, K; Makino, SI
      Effects of recombinant human endostatin on a human neuroblastoma xenograft

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    2. Boiardi, A; Silvani, A; Ciusani, E; Watson, A; Margison, G; Berger, E; Lucas, C; Giroux, B
      Fotemustine combined with procarbazine in recurrent malignant gliomas: A phase I study with evaluation of lymphocyte O-6-alkylguanine-DNA alkyltransferase activity

      JOURNAL OF NEURO-ONCOLOGY
    3. D'Incan, M; Souteyrand, P
      Dacarbazine (Deticene (R))

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    4. Jackel, A; Bock, M; Deichmann, M; Waldmann, V; Naher, H
      Therapy of metastatic malignant uveal melanoma

      HAUTARZT
    5. Lage, H; Helmbach, H; Grottke, C; Dietel, M; Schadendorf, D
      DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells

      FEBS LETTERS
    6. Ikeda, H; Tsuchida, Y; Wu, JG; Suzuki, N; Kuroiwa, M; Choi, SH; Morikawa, A
      Antitumor effects of fotemustine and busulfan against a human neuroblastoma xenograft

      ONCOLOGY REPORTS
    7. Becker, JC; Kampgen, E; Brocker, EB
      Classical chemotherapy for metastatic melanoma

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    8. Middleton, MR; Lee, SM; Arance, A; Wood, M; Thatcher, N; Margison, GP
      O-6-methylguanine formation, repair protein depletion and clinical outcomewith a 4 hr schedule of temozolomide in the treatment of advanced melanoma: Results of phase II study

      INTERNATIONAL JOURNAL OF CANCER
    9. Daponte, A; Ascierto, PA; Gravina, A; Melucci, MT; Palmieri, G; Comella, P; Cellerino, R; DeLena, M; Marini, G; Comella, G
      Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

      CANCER
    10. Lage, H; Helmbach, H; Dietel, M; Schadendorf, D
      Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

      BRITISH JOURNAL OF CANCER
    11. Ilc, K; Ferrero, JM; Fischel, JL; Formento, P; Bryce, R; Etienne, MC; Milano, G
      Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study an human glioblastoma cell lines

      ANTI-CANCER DRUGS
    12. Ulrich, J; Gademann, G; Gollnick, H
      Management of cerebral metastases from malignant melanoma: Results of a combined, simultaneous treatment with fotemustine and irradiation

      JOURNAL OF NEURO-ONCOLOGY
    13. Malhaire, JP; Lucas, B; Simon, H; Person, H; Dam-Hieu, P; Labat, JP
      Fotemustine (Muphoran (R)) in 22 patients with relapses of high-grade cerebral gliomas

      BULLETIN DU CANCER
    14. RICHARD MA; GROB JJ; ZARROUR H; BASSERES N; BIZZARI JP; GERARD B; BONERANDI JJ
      COMBINED TREATMENT WITH DACARBAZINE, CISPLATIN, FOTEMUSTINE AND TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA

      Melanoma research
    15. HAYES MT; BARTLEY J; PARSONS PG
      IN-VITRO EVALUATION OF FOTEMUSTINE AS A POTENTIAL AGENT FOR LIMB PERFUSION IN MELANOMA

      Melanoma research
    16. Semb, KA; Aamdal, S; Bohmann, T; Lucas, C; Gerard, B
      Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma

      MELANOMA RESEARCH
    17. GROB JJ; REGIS J; LAURANS R; DELAUNAY M; WOLKENSTEIN P; PAUL K; SOUTEYRAND P; KOEPPEL MC; MURRACIOLE X; PERRAGUT JC; BONERANDI JJ
      RADIOSURGERY WITHOUT WHOLE-BRAIN RADIOTHERAPY IN MELANOMA BRAIN METASTASES

      European journal of cancer
    18. HARTMANN JT; SCHMOLL E; BOKEMEYER C; FETY R; LUCAS C; GIROUX B; SCHMOLL HJ
      PHASE-I PHARMACOLOGICAL STUDY OF INTRAARTERIALLY INFUSED FOTEMUSTINE FOR COLORECTAL LIVER METASTASES

      European journal of cancer
    19. FALKSON CI; IBRAHIM J; KIRKWOOD JM; COATES AS; ATKINS MB; BLUM RH
      PHASE-III TRIAL OF DACARBAZINE VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B VERSUS DACARBAZINE WITH TAMOXIFEN VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B AND TAMOXIFEN IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    20. Dine, T; Khalfi, F; Gressier, B; Luyckx, M; Brunet, C; Ballester, L; Goudaliez, F; Kablan, J; Cazin, M; Cazin, JC
      Stability study of fotemustine in PVC infusion bags and sets under variousconditions using a stability-indicating high-performance liquid chromatographic assay

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    21. WEICHENTHAL M; MOHR P; STEPHAN U; ALTENHOFF J; KOWALZICK L; MARSEILLE A; SARKANY M; HOSSFELD DK; BREITBART EW
      FOTEMUSTINE AND INTERFERON-ALPHA-2B IN METASTATIC MALIGNANT-MELANOMA

      Journal of cancer research and clinical oncology
    22. TERHEYDEN P; KAMPGEN E; RUNGER TM; BROCKER EB; BECKER JC
      IMMUNOCHEMOTHERAPY OF METASTATIC UVEAL MELANOMA WITH INTERFERON-ALPHA-2B, INTERLEUKIN-2, AND FOTEMUSTINE - CASE-REPORTS AND LITERATURE-REVIEW

      Hautarzt
    23. VERMEULEN NPE; COMMANDEUR JNM; GROOT EJ; WORMHOUDT LW; RAMNATSHING S; LI QJ; BRAKENHOFF JPG
      TOXICITY OF FOTEMUSTINE IN RAT HEPATOCYTES AND MECHANISM-BASED PROTECTION AGAINST IT

      Chemico-biological interactions
    24. HARTMANN JT; SCHMOLL E; BOKEMEYER C; FETY R; LUCAS C; DAGAY L; SCHMOLL HJ
      HEPATIC ARTERIAL INFUSION OF THE NITROSOUREA DERIVATE FOTEMUSTINE FORTHE TREATMENT OF LIVER METASTASES FROM COLORECTAL-CARCINOMA

      Oncology Reports
    25. PONTES L; LOPES M; RIBEIRO M; SANTOS JG; AZEVEDO MC
      ISOLATED LIMB PERFUSION WITH FOTEMUSTINE AFTER CHEMOSENSITIZATION WITH DACARBAZINE IN MELANOMA

      Melanoma research
    26. KLEEBERG UR
      WISHFUL THINKING, UNICENTRIC EMPIRICISM AND THE EVERYDAY WORLD OF THEMEDICAL MELANOMOLOGIST

      Melanoma research
    27. COMELLA P; DAPONTE A; CASARETTI R; IONNA F; FIORE F; PRESUTTI F; FRASCI G; CAPONIGRO F; GRAVINA A; PARZIALE AP; MOZZILLO N; COMELLA G
      FOTERMUSTINE AND DACARBAZINE PLUS RECOMBINANT INTERFERON ALPHA2A IN THE TREATMENT OF ADVANCED MELANOMA

      European journal of cancer
    28. LEYVRAZ S; SPATARO V; BAUER J; PAMPALLONA S; SALMON R; DORVAL T; MEULI R; GILLET M; LEJEUNE F; ZOGRAFOS L
      TREATMENT OF OCULAR MELANOMA METASTATIC TO THE LIVER BY HEPATIC ARTERIAL CHEMOTHERAPY

      Journal of clinical oncology
    29. HARDING MM; KRIPPNER GY; SHELTON CJ; RODGER A; SANDERS KJ; MACKAY JP; PRAKASH AS
      DNA-BINDING STUDIES OF XSPTSPSZ, DERIVATIVES OF THE INTERCALATING HEPTAD REPEAT OF RNA-POLYMERASE-II

      Biopolymers
    30. EWEND MG; CAREY LA; BREM H
      TREATMENT OF MELANOMA METASTASES IN THE BRAIN

      Seminars in surgical oncology
    31. SUPKO JG; PHILLIPS LR; MALSPEIS L
      SPECIFIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY WITH ULTRAVIOLET DETECTION FOR THE DETERMINATION OF 1-(2-CHLOROETHYL)-3-SARCOSINAMIDE-1-NITROSOUREA IN PLASMA

      Journal of chromatography B. Biomedical applications
    32. BROCKER EB; BOHNDORF W; KAMPGEN E; TRCKA J; MESSER P; TILGEN W; ENGENHART K; FLENTJE M
      FOTEMUSTINE GIVEN SIMULTANEOUSLY WITH TOTAL BRAIN IRRADIATION IN MULTIPLE BRAIN METASTASES OF MALIGNANT-MELANOMA - REPORT AN A PILOT-STUDY

      Melanoma research
    33. ROUGIER P; VANPOTTELSBERGHE C; KOK T; PAILLOT B; WAGENER T; DEGREVE J; FABRI MC; GERARD B; VANGLABBEKE M; BLEIBERG H
      FOTEMUSTINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, A PHASE-II TRIAL FROM THE EORTC-GITCCG (EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP)

      European journal of cancer
    34. ILIADIS A; LAUNAYILIADIS MC; LUCAS C; FETY R; LOKIEC F; TRANCHAND B; MILANO G
      PHARMACOKINETICS AND PHARMACODYNAMICS OF NITROSOUREA FOTEMUSTINE - A FRENCH CANCER CENTER MULTICENTRIC STUDY

      European journal of cancer
    35. COTTO C; BERILLE J; SOUQUET PJ; RIOU R; CROISILE B; TURJMAN F; GIROUX B; BRUNE J; TRILLETLENOIR V
      A PHASE-II TRIAL OF FOTEMUSTINE AND CISPLATIN IN CENTRAL-NERVOUS-SYSTEM METASTASES FROM NON-SMALL-CELL LUNG-CANCER

      European journal of cancer
    36. CHOI SH; TSUCHIDA Y; KAMII Y; YANG HW; KOMURO H; MAKINO S
      EFFECTS OF PACLITAXEL, FOTEMUSTINE, IRINOTECAN, MITOMYCIN-C, IFOSFAMIDE AND BLEOMYCIN ON A HIGHLY MALIGNANT XENO-TRANSPLANTED NEUROBLASTOMA

      The Cancer journal
    37. PAUL DR; GAWLIK C; VERSTEEG R; ARPS H; KLEEBERG UR
      CORRELATION BETWEEN THE EXPRESSION OF KI67 AND HLA-DR ANTIGENS IN FOTEMUSTINE-TREATED MELANOMA CELL-LINES

      Onkologie
    38. SHOU J; FENG XW
      DNA-DAMAGE INDUCED BY FOTEMUSTINE IN CULT URED HL-60 CELLS

      Zhongguo yaoli xuebao
    39. RAYMOND E; HAON C; BOAZIZ C; COSTE M
      LOGISTIC-REGRESSION MODEL OF FOTEMUSTINE TOXICITY COMBINING INDEPENDENT PHASE-II STUDIES

      Cancer
    40. PETIT T; BOREL C; RIXE O; AVRIL MF; MONNIER A; GIROUX B; WEIL M; KHAYAT D
      COMPLETE REMISSION 7 YEARS AFTER TREATMENT FOR METASTATIC MALIGNANT-MELANOMA

      Cancer
    41. PUNT CJA; STAMATAKIS L; GERARD B
      FOTEMUSTINE IN PATIENTS WITH RELAPSING MALIGNANT GLIOMAS - A PHASE-IITRIAL

      Oncology Reports
    42. SCHULTEHUERMANN P; ZUMDICK M; RUZICKA T
      SUPRAVENOUS HYPERPIGMENTATION IN ASSOCIATION WITH CHOP CHEMOTHERAPY OF A CD30 (KI-1)-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA

      Dermatology
    43. RIXE O; BOREL C; PARAISO D; BENHAMMOUDA A; PETIT T; ANTOINE E; BIZZARI JP; AUCLERC G; SOUBRANE C; WELL M; GIROUX B; BANZET P; KHAYAT D
      FOTEMUSTINE, DACARBAZINE, VINDESINE COMBINATION CHEMOTHERAPY IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF 43 PATIENTS

      Melanoma research
    44. KLEEBERG UR; ENGEL E; ISRAELS P; BROCKER EB; TILGEN W; KENNES C; GERARD B; LEJEUNE F; GLABBEKE MV; LENTZ MA
      PALLIATIVE THERAPY OF MELANOMA PATIENTS WITH FOTEMUSTINE - INVERSE RELATIONSHIP BETWEEN TUMOR LOAD AND TREATMENT EFFECTIVENESS - A MULTICENTER PHASE-II TRIAL OF THE EORTC-MELANOMA COOPERATIVE GROUP (MCG)

      Melanoma research
    45. KLEEBERG UR; GAWLIK C; BROCKER EB; BOEWER C; CHATELAIN RP; QUEISSER W; WESTERHAUSEN M; ROTHE B; FRIEDRICH G; EDLER L
      INTERFERON-ALPHA-2B AND FOTEMUSTINE IN PATIENTS WITH DISSEMINATED MELANOMA - A MULTICENTER PHASE-II TRIAL OF THE AIO PHASE-I PHASE-II STUDY-GROUP OF THE GERMAN-CANCER-SOCIETY

      Onkologie
    46. FAIRBAIRN LJ; WATSON AJ; RAFFERTY JA; ELDER RH; MARGISON GP
      O-6-BENZYLGUANINE INCREASES THE SENSITIVITY OF HUMAN PRIMARY BONE-MARROW CELLS TO THE CYTOTOXIC EFFECTS OF TEMOZOLOMIDE

      Experimental hematology
    47. LECESNE A; CHABOT G; BERILLE J; LUCAS C; BAUD M; GOUYETTE A; MARTY M; LECHEVALIER T
      PHASE I-II AND PHARMACOKINETIC STUDY OF A NEW FOTEMUSTINE SCHEDULE INADVANCED NON-SMALL-CELL LUNG-CANCER

      Lung cancer
    48. ZHELEVA A; RAIKOV Z; ILARIONOVA M; TODOROV D
      SPIN-LABELED AMINO-ACID NITROSOUREA DERIVATIVES - SYNTHESIS AND ANTITUMOR-ACTIVITY

      Die Pharmazie
    49. CECCHI R; TUCI F; GIOMI A; INNOCENTI F
      SUPRAVENOUS HYPERPIGMENTATION INDUCED BY VINORELBINE

      Dermatology
    50. RIVIERE A; LECESNE A; BERILLE J; BAIO S; LECHEVALIER T
      CISPLATIN-FOTEMUSTINE COMBINATION IN INOPERABLE NONSMALL CELL LUNG-CANCER - PRELIMINARY-REPORT OF A FRENCH MULTICENTER PHASE-II TRIAL

      European journal of cancer
    51. KHAYAT D; GIROUX B; BERILLE J; COUR V; GERARD B; SARKANY M; BERTRAND P; BIZZARI JP
      FOTEMUSTINE IN THE TREATMENT OF BRAIN PRIMARY TUMORS AND METASTASES

      Cancer investigation
    52. RUDD R; ALLEN R; BERILLE J; SPIRO SG; TRASK C; SOUHAMI RL
      PHASE-II STUDY OF FOTEMUSTINE IN UNTREATED INOPERABLE NON-SMALL-CELL LUNG-CANCER

      Cancer chemotherapy and pharmacology
    53. FALKSON CI; FALKSON G; FALKSON HC
      PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA

      Investigational new drugs
    54. GODENECHE D; LABARRE P; CUSSAC C; MADELMONT JC; DUPUY JM; FONTANON C; TISSERANT A; CHOLLET P; BAUDRY JP; VEYRE A
      PHARMACOKINETICS OF 2 NEW 2-CHLOROETHYLNITROSOUREAS IN CANCER-PATIENTS SUBMITTED TO PHASE-II CLINICAL-TRIALS

      Drug investigation
    55. KOLLER CA; GORSKI CC; BENJAMIN RS; LEGHA SS; PAPADOPOULOS NE; PLAGER C
      A PHASE-I TRIAL OF WEEKLY LOMUSTINE IN PATIENTS WITH ADVANCED CANCER

      Cancer
    56. FISCHEL JL; BARBE V; BERLION M; FORMENTO P; BERRILE J; BIZZARI JP; MILANO G
      TAMOXIFEN ENHANCES THE CYTOTOXIC EFFECTS OF THE NITROSOUREA FOTEMUSTINE - RESULTS ON HUMAN-MELANOMA CELL-LINES

      Bulletin du cancer
    57. ISRAELS SP
      IS THERE A ROLE FOR CHEMOTHERAPY IN HEAD AND NECK MELANOMA - A CRITICAL-REVIEW OF RECENT TRIALS WITH CHEMOTHERAPY

      Diagnostic oncology
    58. KUNKEL D; CARLOZ E; PRIGNET JM; HOUDELETTE P; JAUBERT D; DEJAUREGUIBERRY JP; GAGLIANOGIUNTA MG
      MALIGNANT-MELANOMA OF THE ESOPHAGUS

      Gastroenterologie clinique et biologique
    59. CELERIER P; DRENO B; BUREAU B; LITOUX P
      COMBINATION CHEMOTHERAPY OF FOTEMUSTINE-D ACARBAZINE AND INTERFERON-ALPHA FOR DISSEMINATED MALIGNANT-MELANOMA TREATMENT

      Annales de dermatologie et de venereologie
    60. BOREL AG; ABBOTT FS
      IDENTIFICATION OF CARBAMOYLATED THIOL CONJUGATES AS METABOLITES OF THE ANTINEOPLASTIC 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA, IN RATSAND HUMANS

      Drug metabolism and disposition
    61. BOAZIZ C; MAZERON JJ; MORERE JF; BREAU JL; ISRAEL L
      UVEAL MELANOMA

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 00:27:15